Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Vitamin K status, supplementation and vascular disease: a systematic review and meta-analysis.

Lees JS, Chapman FA, Witham MD, Jardine AG, Mark PB.

Heart. 2019 Jun;105(12):938-945. doi: 10.1136/heartjnl-2018-313955. Epub 2018 Dec 4.

PMID:
30514729
2.

Long-term renal allograft survival: a quiet revolution.

Jardine AG, Hartmann A, Holdaas H.

Kidney Int. 2018 Nov;94(5):853-855. doi: 10.1016/j.kint.2018.08.005.

PMID:
30348301
3.

Inequality in Care and Differences in Outcome Following Stroke in People With ESRD.

Findlay MD, Dawson J, MacIsaac R, Jardine AG, MacLeod MJ, Metcalfe W, Traynor JP, Mark PB.

Kidney Int Rep. 2018 Apr 27;3(5):1064-1076. doi: 10.1016/j.ekir.2018.04.011. eCollection 2018 Sep.

4.

Pulse Pressure: A Risk Factor for Renal Transplant Failure or a Useful Therapeutic Target?

Tunbridge M, Holdaas H, Jardine AG.

Transplantation. 2019 Apr;103(4):662-663. doi: 10.1097/TP.0000000000002441. No abstract available.

PMID:
30188414
5.

Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease.

Gillis K, Stevens KK, Bell E, Patel RK, Jardine AG, Morris STW, Schneider MP, Delles C, Mark PB.

Clin Kidney J. 2018 Aug;11(4):532-539. doi: 10.1093/ckj/sfx158. Epub 2018 Feb 6.

6.

Non-uniform relationship between salt status and aldosterone activity in patients with chronic kidney disease.

Taylor AHM, Rankin AJ, McQuarrie EP, Freel EM, Homer NZM, Andrew R, Jardine AG, Mark PB.

Clin Sci (Lond). 2018 Jan 25;132(2):285-294. doi: 10.1042/CS20171603. Print 2018 Jan 31.

PMID:
29321218
7.

Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study.

Rutherford E, Mangion K, McComb C, Bell E, Cockburn S, Talle M, Roditi G, Welsh P, Woodward R, Radjenovic A, Struthers AD, Jardine AG, Berry C, Patel RK, Mark PB.

Sci Rep. 2017 Oct 25;7(1):13976. doi: 10.1038/s41598-017-14481-y.

8.

An Open-Label Dose-Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients.

Rutherford E, Stewart G, Houston JG, Jardine AG, Mark PB, Struthers AD.

J Clin Pharmacol. 2017 Nov;57(11):1409-1414. doi: 10.1002/jcph.939. Epub 2017 Jun 9. No abstract available.

9.

Correction: Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection.

Rose J, Emery VC, Kumar D, Asberg A, Hartmann A, Jardine AG, Bignamini AA, Humar A, Neumann AU.

PLoS Pathog. 2017 May 10;13(5):e1006386. doi: 10.1371/journal.ppat.1006386. eCollection 2017 May.

10.

Belatacept: Where the BENEFITS Outweigh the Risk.

Holdaas H, Mjøen G, Jardine AG.

Am J Kidney Dis. 2017 May;69(5):561-563. doi: 10.1053/j.ajkd.2017.02.007. No abstract available.

PMID:
28434523
11.

Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection.

Rose J, Emery VC, Kumar D, Asberg A, Hartmann A, Jardine AG, Bignamini AA, Humar A, Neumann AU.

PLoS Pathog. 2017 Apr 13;13(4):e1006299. doi: 10.1371/journal.ppat.1006299. eCollection 2017 Apr. Erratum in: PLoS Pathog. 2017 May 10;13(5):e1006386.

12.

Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.

Fellström BC, Barratt J, Cook H, Coppo R, Feehally J, de Fijter JW, Floege J, Hetzel G, Jardine AG, Locatelli F, Maes BD, Mercer A, Ortiz F, Praga M, Sørensen SS, Tesar V, Del Vecchio L; NEFIGAN Trial Investigators.

Lancet. 2017 May 27;389(10084):2117-2127. doi: 10.1016/S0140-6736(17)30550-0. Epub 2017 Mar 28.

PMID:
28363480
13.

Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients: A Guidance Report and Clinical Checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) Group.

Neuberger JM, Bechstein WO, Kuypers DR, Burra P, Citterio F, De Geest S, Duvoux C, Jardine AG, Kamar N, Krämer BK, Metselaar HJ, Nevens F, Pirenne J, Rodríguez-Perálvarez ML, Samuel D, Schneeberger S, Serón D, Trunečka P, Tisone G, van Gelder T.

Transplantation. 2017 Apr;101(4S Suppl 2):S1-S56. doi: 10.1097/TP.0000000000001651.

PMID:
28328734
14.

A national appraisal of haemodialysis vascular access provision in Scotland.

Oliver SW, Campbell J, Kingsmore DB, Kasthuri R, Metcalfe W, Traynor JP, Fischbacher-Smith D, Jardine AG, Thomson PC.

J Vasc Access. 2017 Mar 21;18(2):126-131. doi: 10.5301/jva.5000651. Epub 2017 Jan 31.

PMID:
28165579
15.

Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation.

Wadström J, Ericzon BG, Halloran PF, Bechstein WO, Opelz G, Serón D, Grinyó J, Loupy A, Kuypers D, Mariat C, Clancy M, Jardine AG, Guirado L, Fellström B, O'Grady J, Pirenne J, O'Leary JG, Aluvihare V, Trunečka P, Baccarani U, Neuberger J, Soto-Gutierrez A, Geissler EK, Metzger M, Gray M.

Transplantation. 2017 Feb;101 Suppl 2S:S1-S41. doi: 10.1097/TP.0000000000001563. No abstract available.

PMID:
28125449
16.

Predictors of atherosclerotic events in patients on haemodialysis: post hoc analyses from the AURORA study.

Solbu MD, Mjøen G, Mark PB, Holdaas H, Fellström B, Schmieder RE, Zannad F, Herrington WG, Jardine AG.

Nephrol Dial Transplant. 2018 Jan 1;33(1):102-112. doi: 10.1093/ndt/gfw360.

PMID:
27798199
17.

Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis.

Currie G, Taylor AH, Fujita T, Ohtsu H, Lindhardt M, Rossing P, Boesby L, Edwards NC, Ferro CJ, Townend JN, van den Meiracker AH, Saklayen MG, Oveisi S, Jardine AG, Delles C, Preiss DJ, Mark PB.

BMC Nephrol. 2016 Sep 8;17(1):127. doi: 10.1186/s12882-016-0337-0. Review.

18.

Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.

Rutherford E, Talle MA, Mangion K, Bell E, Rauhalammi SM, Roditi G, McComb C, Radjenovic A, Welsh P, Woodward R, Struthers AD, Jardine AG, Patel RK, Berry C, Mark PB.

Kidney Int. 2016 Oct;90(4):845-52. doi: 10.1016/j.kint.2016.06.014. Epub 2016 Aug 5.

19.

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.

Cholesterol Treatment Trialists' (CTT) Collaboration, Herrington WG, Emberson J, Mihaylova B, Blackwell L, Reith C, Solbu MD, Mark PB, Fellström B, Jardine AG, Wanner C, Holdaas H, Fulcher J, Haynes R, Landray MJ, Keech A, Simes J, Collins R, Baigent C.

Lancet Diabetes Endocrinol. 2016 Oct;4(10):829-39. doi: 10.1016/S2213-8587(16)30156-5. Epub 2016 Jul 29.

20.

Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway.

Stevens KK, Denby L, Patel RK, Mark PB, Kettlewell S, Smith GL, Clancy MJ, Delles C, Jardine AG.

Nephrol Dial Transplant. 2017 Oct 1;32(10):1617-1627. doi: 10.1093/ndt/gfw252.

21.

Risk factors and outcome of stroke in renal transplant recipients.

Findlay MD, Thomson PC, MacIsaac R, Jardine AG, Patel RK, Stevens KK, Rutherford E, Clancy M, Geddes CC, Dawson J, Mark PB.

Clin Transplant. 2016 Aug;30(8):918-24. doi: 10.1111/ctr.12765. Epub 2016 Jun 21.

PMID:
27218240
22.

Research cardiac magnetic resonance imaging in end stage renal disease - incidence, significance and implications of unexpected incidental findings.

Rutherford E, Weir-McCall JR, Patel RK, Houston JG, Roditi G, Struthers AD, Jardine AG, Mark PB.

Eur Radiol. 2017 Jan;27(1):315-324. Epub 2016 Apr 7.

23.

High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime.

Whalen HR, Glen JA, Harkins V, Stevens KK, Jardine AG, Geddes CC, Clancy MJ.

Transplantation. 2017 Feb;101(2):430-436. doi: 10.1097/TP.0000000000001129.

PMID:
26950724
24.

Differential visceral blood flow in the hyperdynamic circulation of patients with liver cirrhosis.

McAvoy NC, Semple S, Richards JM, Robson AJ, Patel D, Jardine AG, Leyland K, Cooper AS, Newby DE, Hayes PC.

Aliment Pharmacol Ther. 2016 May;43(9):947-54. doi: 10.1111/apt.13571. Epub 2016 Mar 7.

25.

Lessons Learned From a Randomized Study of Oral Valganciclovir Versus Parenteral Ganciclovir Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients: The VICTOR Trial.

Åsberg A, Humar A, Rollag H, Jardine AG, Kumar D, Aukrust P, Ueland T, Bignamini AA, Hartmann A.

Clin Infect Dis. 2016 May 1;62(9):1154-60. doi: 10.1093/cid/ciw084. Epub 2016 Feb 16.

PMID:
26908810
26.

Serum phosphate and social deprivation independently predict all-cause mortality in chronic kidney disease.

Solbu MD, Thomson PC, Macpherson S, Findlay MD, Stevens KK, Patel RK, Padmanabhan S, Jardine AG, Mark PB.

BMC Nephrol. 2015 Dec 1;16:194. doi: 10.1186/s12882-015-0187-1.

27.

'To block or not to block'; whether to continue renin-angiotensin-aldosterone system blockade in advanced chronic kidney disease.

Solbu MD, Jardine AG.

Nephrol Dial Transplant. 2016 Feb;31(2):171-3. doi: 10.1093/ndt/gfv351. Epub 2015 Oct 6. No abstract available.

PMID:
26445812
28.

Association between serum phosphate and calcium, long-term blood pressure, and mortality in treated hypertensive adults.

Patel RK, Jeemon P, Stevens KK, Mccallum L, Hastie CE, Schneider A, Jardine AG, Mark PB, Padmanabhan S.

J Hypertens. 2015 Oct;33(10):2046-53. doi: 10.1097/HJH.0000000000000659.

PMID:
26431193
29.

Phosphate as a cardiovascular risk factor: effects on vascular and endothelial function.

Stevens KK, Patel RK, Mark PB, Delles C, Jardine AG.

Lancet. 2015 Feb 26;385 Suppl 1:S10. doi: 10.1016/S0140-6736(15)60325-7.

PMID:
26312829
30.

Opponent's comments.

Jardine AG.

Nephrol Dial Transplant. 2015 Sep;30(9):1437-8. doi: 10.1093/ndt/gfv243a. Review. No abstract available.

PMID:
26311657
31.

Risk Factors of Ischemic Stroke and Subsequent Outcome in Patients Receiving Hemodialysis.

Findlay MD, Thomson PC, Fulton RL, Solbu MD, Jardine AG, Patel RK, Stevens KK, Geddes CC, Dawson J, Mark PB.

Stroke. 2015 Sep;46(9):2477-81. doi: 10.1161/STROKEAHA.115.009095. Epub 2015 Jul 30.

PMID:
26230856
32.

Con: Ambulatory blood pressure measurement in patients receiving haemodialysis: a sore arm and a waste of time?

Jardine AG.

Nephrol Dial Transplant. 2015 Sep;30(9):1438-41. doi: 10.1093/ndt/gfv244. Epub 2015 May 28.

PMID:
26022726
33.

Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study.

Drechsler C, Pihlstrøm H, Meinitzer A, Pilz S, Tomaschitz A, Abedini S, Fellstrom B, Jardine AG, Wanner C, März W, Holdaas H.

Transplantation. 2015 Jul;99(7):1470-6. doi: 10.1097/TP.0000000000000568.

PMID:
25675199
34.

Safe central venous catheter insertion practice must extend beyond simply measuring catheter-associated bloodstream infections.

Oliver SW, Thomson PC, Jardine AG.

J Hosp Infect. 2015 May;90(1):81. doi: 10.1016/j.jhin.2014.11.021. Epub 2015 Jan 7. No abstract available.

PMID:
25617090
35.

Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism.

Pihlstrøm H, Dahle DO, Mjøen G, Pilz S, März W, Abedini S, Holme I, Fellström B, Jardine AG, Holdaas H.

Transplantation. 2015 Feb;99(2):351-9. doi: 10.1097/TP.0000000000000583.

PMID:
25594550
36.

Socio-economic status influences chronic kidney disease prevalence in primary care: a community-based cross-sectional analysis.

So BH, Methven S, Hair MD, Jardine AG, MacGregor MS.

Nephrol Dial Transplant. 2015 Jun;30(6):1010-7. doi: 10.1093/ndt/gfu408. Epub 2015 Jan 13.

PMID:
25586406
37.

Proceedings of the 13th international transplantation symposia: mTOR-inhibition: what have we learned and how so we best apply the learning.

Jardine AG.

Transplant Res. 2015 Dec 22;4(Suppl 1):4. doi: 10.1186/s13737-015-0027-7. eCollection 2015. No abstract available.

38.

Effect of left atrial and ventricular abnormalities on renal transplant recipient outcome-a single-center study.

Patel RK, Pennington C, Stevens KK, Taylor A, Gillis K, Rutherford E, Johnston N, Jardine AG, Mark PB.

Transplant Res. 2014 Dec 3;3(1):20. doi: 10.1186/s13737-014-0020-6. eCollection 2014.

39.

Cardiovascular morbidity and mortality after kidney transplantation.

Stoumpos S, Jardine AG, Mark PB.

Transpl Int. 2015 Jan;28(1):10-21. doi: 10.1111/tri.12413. Epub 2014 Aug 20. Review.

40.

Association between urinary sodium, creatinine, albumin, and long-term survival in chronic kidney disease.

McQuarrie EP, Traynor JP, Taylor AH, Freel EM, Fox JG, Jardine AG, Mark PB.

Hypertension. 2014 Jul;64(1):111-7. doi: 10.1161/HYPERTENSIONAHA.113.03093. Epub 2014 Apr 14.

PMID:
24732890
41.

BP targets in renal transplant recipients: too high or too low?

Holdaas H, Jardine AG.

J Am Soc Nephrol. 2014 Jul;25(7):1371-3. doi: 10.1681/ASN.2014020177. Epub 2014 Mar 13. No abstract available.

42.

How is the heart best protected in chronic dialysis patients?: Is there life in the old drugs yet? Mineralocorticoid receptor antagonism for cardiovascular prevention in chronic dialysis patients.

Mark PB, Taylor AH, McQuarrie EP, Jardine AG.

Semin Dial. 2014 Jul-Aug;27(4):328-32. doi: 10.1111/sdi.12178. Epub 2014 Feb 5. Review. No abstract available.

PMID:
24499322
43.

Inter-study reproducibility of arterial spin labelling magnetic resonance imaging for measurement of renal perfusion in healthy volunteers at 3 Tesla.

Gillis KA, McComb C, Foster JE, Taylor AH, Patel RK, Morris ST, Jardine AG, Schneider MP, Roditi GH, Delles C, Mark PB.

BMC Nephrol. 2014 Jan 31;15:23. doi: 10.1186/1471-2369-15-23.

44.

Cardiovascular complications after transplantation: treatment options in solid organ recipients.

Gillis KA, Patel RK, Jardine AG.

Transplant Rev (Orlando). 2014 Apr;28(2):47-55. doi: 10.1016/j.trre.2013.12.001. Epub 2013 Dec 11. Review.

PMID:
24412041
45.

Bring on the weekend - Improving the quality of junior doctor weekend handover.

Jardine AG, Page T, Bethune R, Mourant P, Deol P, Bowden C, Dahill M, Mische C, Cornish N, Sanders V, Lee J, Bethune R.

BMJ Qual Improv Rep. 2014 Jan 8;2(2). pii: u202379.w1297. doi: 10.1136/bmjquality.u202379.w1297. eCollection 2014.

46.

Secreted Wnt antagonists during eradication of cytomegalovirus infection in solid organ transplant recipients.

Ueland T, Rollag H, Hartmann A, Jardine AG, Humar A, Michelsen AE, Bignamini AA, Åsberg A, Aukrust P.

Am J Transplant. 2014 Jan;14(1):210-5. doi: 10.1111/ajt.12506. Epub 2013 Nov 13.

47.

Prophylactic ciprofloxacin for kidney transplant recipients--to add or not to add.

Patel RK, Taylor A, Jardine AG.

Transplantation. 2013 Aug 27;96(4):370-1. doi: 10.1097/TP.0b013e31829e2723. No abstract available.

PMID:
23860085
48.

Proteinuria and outcome after renal transplantation: ratios or fractions?

Stevens KK, Patel RK, Methven S, Clancy MJ, Fox JG, Jardine AG, Geddes CC.

Transplantation. 2013 Jul 15;96(1):65-9. doi: 10.1097/TP.0b013e318295852c.

PMID:
23715051
49.

Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma.

Rollag H, Ueland T, Asberg A, Hartmann A, Jardine AG, Humar A, Pescovitz MD, Bignamini AA, Aukrust P.

PLoS One. 2013 Apr 8;8(4):e60767. doi: 10.1371/journal.pone.0060767. Print 2013.

50.

Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetes.

Schneider A, Schneider MP, Scharnagl H, Jardine AG, Wanner C, Drechsler C.

BMC Nephrol. 2013 Mar 22;14:67. doi: 10.1186/1471-2369-14-67.

Supplemental Content

Loading ...
Support Center